價(jià)格 | ¥1138 | ¥1980 | ¥3200 |
包裝 | 50ul | 100ul | 200ul |
最小起訂量 | 50ul |
發(fā)貨地 | 上海 |
更新日期 | 2025-01-17 |
中文名稱:Anti-phospho-AKT1 antibody-磷酸化蛋白激酶AKT1抗體 | 英文名稱:phospho-AKT1(Ser124) |
品牌: 滬震生物 | 產(chǎn)地: 中國/上海 |
保存條件: -20°C | 純度規(guī)格: > 99% |
產(chǎn)品類別: 抗體 一抗 | |
抗體名: p-AKT1 (phospho S124); phospho-AKT1(Ser124); AKT1 (phospho S2124); AKT 1; AKT; AKT1; AKT1_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1. | 靶點(diǎn): 詳見說明書 |
宿主: Rabbit | 適應(yīng)物種: 詳見說明書 |
克隆性: 詳見說明書 | 濃度: 1mg/ml |
應(yīng)用范圍: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:400-800 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. | 標(biāo)識(shí)物: 詳見說明書 |
形態(tài): 液體 | 亞型: IgG1 |
免疫原: 詳見說明書 | 貨號(hào): Hz-R2849 |
用途范圍: 科研使用 | 規(guī)格: 50ul/100ul/200ul |
是否進(jìn)口: 否 | 是否單克隆: 詳見說明書p55 |
保質(zhì)期: 12個(gè)月 | 抗原來源: 詳見說明書 |
標(biāo)記物: 詳見說明書 | 產(chǎn)品用途: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:400-800 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
Host:Rabbit
Target Protein:phospho-AKT1(Ser124)
IR:Immunogen Range:SG(p-S)PS
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:207
Swiss Prot:P31749
Source:KLH conjugated synthesised phosphopeptide derived from human AKT1 around the phosphorylation site of Ser124 :SG(p-S)PS
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
Size:50ul
Concentration:1mg/ml
Applications:WB(1:500-2000)
ELISA(1:5000-10000)
IHC-P(1:400-800)
Cross Reactive Species:Human
Rat
Horse
本產(chǎn)品僅供科研使用。不能用于人和動(dòng)物治療等其它臨床診斷用!
成立日期 | 2014-05-08 (11年) | 注冊(cè)資本 | 100萬元整 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥960.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2025-01-24 | |
詢價(jià) |
上海炎熙生物科技有限公司
|
2025-01-30 | ||
詢價(jià) |
上海博湖生物科技有限公司
|
2025-01-30 |